High throughput screen identifies lysosomal acid phosphatase 2 (ACP2) to regulate IFN-1 responses to potentiate oncolytic VSV△51 activitySCIENTIFIC REPORTSIF3.92024-11-160OAAI
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVA51 oncolytic virotherapyMOLECULAR THERAPYIF122023-11-017OAAI
Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinomaBRITISH JOURNAL OF DERMATOLOGYIF9.62023-10-210PRE
Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapyMOLECULAR THERAPY-ONCOLYTICSIF02022-06-016OAAI
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergyCOMMUNICATIONS BIOLOGYIF5.12020-05-2212OAAI
Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibitionSCIENCE TRANSLATIONAL MEDICINEIF14.62018-01-2443OAAI
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium CompoundsMOLECULAR THERAPYIF122018-01-0174OAAI
Oncolytic Maraba Virus MG1 as a Treatment for SarcomaINTERNATIONAL JOURNAL OF CANCERIF4.72017-06-2137OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向